Immunotherapeutic strategies for neoplasia.
Talmadge
J E
JE
University of Nebraska Med. Center, Dept. of Pathology and Microbiology, Omaha 68198.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods; D003131:Combined Modality Therapy; D015195:Drug Design; D004341:Drug Evaluation / Q000379:methods; D004347:Drug Interactions; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods*; D051379:Mice; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000628:therapy
D000970:Antineoplastic Agents; D007155:Immunologic Factors